Actively Recruiting
Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer
Led by Massachusetts General Hospital · Updated on 2024-11-25
250
Participants Needed
3
Research Sites
173 weeks
Total Duration
On this page
Sponsors
M
Massachusetts General Hospital
Lead Sponsor
U
United States Department of Defense
Collaborating Sponsor
AI-Summary
What this Trial Is About
Multi-site randomized trial of the THRIVE digital health application versus usual care to evaluate the effect of THRIVE on quality of life (QOL), physical and psychological symptoms, coping, and self-efficacy in 250 patients with newly diagnosed advanced lung cancer.
CONDITIONS
Official Title
Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Diagnosed with advanced non-small cell lung cancer (NSCLC) not treated with curative intent or extensive stage small cell lung cancer (SCLC) within the past 12 weeks
- Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 2 (fully active to ambulatory for more than 50% of waking hours)
- Sufficient English proficiency to use the THRIVE app (outcome measures may be completed in Spanish)
You will not qualify if you...
- Significant uncontrolled psychiatric disorder such as psychotic disorder, bipolar disorder, or major depression
- Other co-morbid diseases like dementia or cognitive impairment reported by the treating clinician as preventing study participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
University of California Los Angeles
Los Angeles, California, United States, 90024
Actively Recruiting
2
Veteran Affairs Greater Los Angeles Health Care
Los Angeles, California, United States, 90073
Not Yet Recruiting
3
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Actively Recruiting
Research Team
J
Jennifer Temel
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here